IQVIA Holdings Inc. (IQV) News
Filter IQV News Items
IQV News Results
|Loading, please wait...|
IQV News Highlights
- For IQV, its 30 day story count is now at 12.
- Over the past 28 days, the trend for IQV's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
- DCT, ACN and DOCU are the most mentioned tickers in articles about IQV.
Latest IQV News From Around the Web
Below are the latest news stories about IQVIA HOLDINGS INC that investors may wish to consider to help them evaluate IQV as an investment opportunity.
RESEARCH TRIANGLE PARK, N.C., October 03, 2022--IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV) will announce its third-quarter 2022 financial results before the market opens on Wednesday, October 26, 2022. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that same day. The earnings release and accompanying financial information will be posted on the IQVIA Investor Relations website at http://ir.iqvia.com.
RESEARCH TRIANGLE PARK, N.C., September 28, 2022--IQVIA (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and contract services to the life sciences industry, today announced its Decentralized Clinical Trial (DCT) program has received GDPR compliance validation from TRUSTArc. This marks the first instance of a DCT service receiving this European data privacy validation.
Paychex's (PAYX) first-quarter fiscal 2023 earnings and revenues are likely to have surged from the respective year-ago fiscal quarter's levels.
In this piece, we will take a look at the top ten stocks to buy today according to billionaire Thomas Steyer. For more stocks, head on over to 5 Best Stocks to Buy Now According to Billionaire Thomas Steyer. Thomas Steyer is a former American hedge fund investor who helped set up the fund Farallon […]
Accenture (ACN) delivered earnings and revenue surprises of 1.17% and 0.17%, respectively, for the quarter ended August 2022. Do the numbers hold clues to what lies ahead for the stock?
The best growth stocks to buy in October -- or anytime -- are those that will benefit from long-term market trends.
Accentures' (ACN) fourth-quarter fiscal 2022 earnings are expected to have benefited from higher revenues and operating results, lower interest and a fall in non-operating expenses.
While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...
FactSet's (FDS) fourth-quarter fiscal 2022 earnings and revenues are expected to have increased year over year.
IQVIA's (IQV) enormous treasure trove of information is a distinguishing asset.